ArticleThe World Allergy Organization journal2026
Olfactory mucosal inflammation and barrier disruption correlate with perceived CRSwNP-associated olfactory dysfunction.
Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to characterize the local inflammatory and histopathological features of the olfactory mucosa (OM) in patients with CRSwNP and to clarify how these local changes are associated with perceived olfactory dysfunction. Methods: OM specimens were collected from patients with CRSwNP during FESS and from control subjects undergoing endoscopic transnasal skull base surgery, with sampling restricted to the olfactory region under endoscopic guidance. qRT-PCR was performed in 30 CRSwNP and 13 control samples to quantify inflammatory mediators, and immunofluorescence staining was performed in 18 CRSwNP and 10 control samples to assess epithelial cell composition, tight junction proteins, and inflammatory cell infiltration. Clinical symptoms were evaluated using VAS and SNOT-22. Results: Compared with controls, the OM of patients with CRSwNP showed significantly increased expression of TNF-α, IFN-γ, IL-5, IL-13, CLC, CCL11, and CCL18. More severe smell loss was associated with a type 2 inflammatory endotype, eosinophilic CRSwNP, and older age. Among the inflammatory mediators examined, IL-5 showed the clearest positive association with smell loss severity, while IL-13, CLC, and CCL11 provided additional support for a type 2 inflammatory pattern linked to olfactory dysfunction. Patients with severe smell loss also exhibited a greater local inflammatory burden, particularly increased IL-5, CLC, and CCL11. Histologically, CRSwNP OM demonstrated reduced OMP-positive olfactory sensory neurons and KRT18-positive sustentacular cells, increased KRT5-positive basal cells, decreased Golf expression, and downregulation of ZO-1, Occludin, Claudin-1, and Claudin-3, together with increased infiltration of CD45 Conclusion: Perceived olfactory dysfunction in CRSwNP was closely associated with an active local immune-inflammatory microenvironment in the olfactory mucosa, characterized by predominant type 2/eosinophilic inflammation, epithelial injury, abnormal repair, barrier disruption, and immune cell infiltration. Among the inflammatory markers examined, IL-5 showed the strongest association with the severity of olfactory dysfunction, while CLC and CCL11 may serve as candidate local tissue markers of inflammatory burden in CRSwNP-associated olfactory dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.